Who We Are
- Member Directory
  Looking for someone? Search IUPAC global network.
- Organizational Chart
  A Graph is Worth a Thousand Words.
- Strategic Plan
  Our mission, vision, values and unique place in the world.
- Divisions
  The fields of chemistry covered by IUPAC volunteers.
- Committees
  Advisory and operational bodies serving our community.
- Governance
  IUPAC Statutes, Bylaws, and Standing Orders.
- Leadership
  In office from two to eight years, the officers serve the Union as volunteers.
- Secretariat
  Meet the staff who support IUPAC and its activities.
- History
  From global chemists’ need for standardization and the vision to unite.
What We Do
- Periodic Table of Elements
  Latest release based on the work of the Commission on Isotopic Abundances and Atomic Weights.
- Top 10 Emerging Technologies
  Annual selection showcasing the value and importance of Chemistry.
- Recommendations and Reports
  Unambiguous and consistent nomenclature and terminology, evaluation of data, methods or techniques, guidelines and more.
- Nomenclature
  The expertise IUPAC is known for.
- Digital Standards
  Chemical standards for the digital workplace, e.g. InChI, ThermoML, JCAMP-DX.
- Databases
  Resources to search and retrieve output of IUPAC research activities.
- Journals
  Peer reviewed and open access publications, including PAC, CTI, CI, MS, and SDS.
- Color Books
  Authoritative resources for chemical nomenclature, terminology, and symbols.
- Awards
  Honoring scientists from early career to expert level chemists.
- JCGM
  The Joint Committee for Guides in Metrology.
- Projects
  How we do what we do and how we get the word out.
- Conferences
  Endorsement program and financial support opportunities.
Events
Projects
News

Y158 — Kristina =link=

Beyond stock photography, has gained traction within the digital art community, specifically among 3D character sculptors and pose artists .

The following essay explores the biochemical significance of the y158 kristina

: The study identifies activated FGFR3 (Fibroblast Growth Factor Receptor 3) as a primary driver of resistance to PARP inhibitors (PARPi) in triple-negative breast cancer (TNBC). Beyond stock photography, has gained traction within the